A Study of IVX-A12 in Adults Participants
Public ClinicalTrials.gov record NCT06481579. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Modified Double-Blind, Active Controlled Study to Characterize the Safety and Immunogenicity of IVX-A12 in Adults 60 Years of Age and Older
Study identification
- NCT ID
- NCT06481579
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Icosavax, Inc.
- Industry
- Enrollment
- 143 participants
Conditions and interventions
Conditions
Interventions
- IVX-A12 Biological
- Licensed RSV Vaccine Biological
Biological
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 9, 2024
- Primary completion
- Jul 16, 2024
- Completion
- Dec 18, 2024
- Last update posted
- Aug 25, 2025
2024
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Icosavax Investigational Site US022 | Anaheim | California | 92801 | — |
| Icosavax Investigational Site US021 | Rolling Hills Estates | California | 90274 | — |
| Icosavax Investigational Site US002 | Hollywood | Florida | 33024 | — |
| Icosavax Investigational Site US011 | Lenexa | Kansas | 66219 | — |
| Icosavax Investigational Site US016 | North Charleston | South Carolina | 29405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06481579, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06481579 live on ClinicalTrials.gov.